Stockscreener 앱 받기
34.50
0.28%
-0.0953
전일 마감가:
$34.60
열려 있는:
$34.66
하루 거래량:
9,545
Relative Volume:
0.74
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.31%
1개월 성능:
+9.49%
6개월 성능:
+24.59%
1년 성능:
+30.98%
1일 변동 폭
$34.34
$34.69
1주일 범위
$32.51
$34.93
52주 변동 폭
$20.01
$34.93
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
OZEM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
34.50 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.76 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
262.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf 주식(OZEM)의 최신 뉴스
Can You Buy Ozempic Stock in 2025? - The Motley Fool
Best-Performing ETFs of November - Nasdaq
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
N-PX: Others - 富途牛牛
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - Yahoo Finance
Roundhill GLP-1 & Weight Loss ETF Review and Aggregate Rating (OZEM) - MarketBeat
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)Dividends - intelligentinvestor.com.au
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Zacks Investment Research
Roundhill GLP-1 & Weight Loss ETF (OZEM) Institutional Ownership 2025 - MarketBeat
Roundhill GLP-1 & Weight Loss ETF (OZEM) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
OZEM Financial Statements & ChartsRoundhill Etf TrustRoundhill Glp-1 & Weight Loss Etf MacroTrends - CMLviz
Roundhill Glp-1 & Weight Loss ETF (OZEM) Holdings - Yahoo! Finance Canada
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Roundhill Glp-1 & Weight Loss ETF (OZEM) holdings - Yahoo Finance UK
The FSA Spy market buzz – 31 May 2024 - Fund Selector Asia
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - Sahm
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
OZEM: ROUNDHILL GLP-1 & WEIGHT LOSS ETFFund Chart - Zacks Investment Research
Roundhill ETF TrustRoundhill GLP-1 & Weight Loss ETF - CMLviz
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
Roundhill GLP-1 & Weight Loss ETF (OZEM) Stock Trends and Sentiment 2025 - MarketBeat
Roundhill Glp 1 Weight Loss Etf (OZEM) 재무 분석
Roundhill Glp 1 Weight Loss Etf (OZEM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.33%
자본화:
|
볼륨(24시간):